Atlas Trials

Nexavar for Neoadjuvant Treatment of Anaplastic Thyroid Cancer

Clinical trial NCT03565536 · COMPLETED

Trial details

NCT number
NCT03565536
Sponsor
Fujian Medical University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Thyroid Cancer, Anaplastic
Start date
2018-05-01
Primary completion
2020-12-30
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.